INVIVO THERAPEUTICS HOLDINGS C
Reported by CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Reported 0 shares, down 58,398 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
67 managers reported INVIVO THERAPEUTICS HOLDINGS C for Q2 2017.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 926,766 | -197,862 | < 0.01% | $2,503,000 | 9 qtrs |
| BlackRock Inc | Reduced | 583,793 | -1,370,529 | < 0.01% | $1,577,000 | 9 qtrs |
| Legal & General Group Plc | Added | 503,407 | +492,289 | < 0.01% | $1,359,000 | 5 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 421,564 | +409,775 | < 0.01% | $1,138,000 | 5 qtrs |
| WELCH & FORBES LLC | Reduced | 400,614 | -108,035 | 0.03% | $1,081,000 | 9 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 400,000 | 0 | < 0.01% | $1,080,000 | 6 qtrs |
| IMS Capital Management | Reduced | 391,149 | -44,839 | 1.0% | $1,056,000 | 9 qtrs |
| STATE STREET CORPORATION | Reduced | 384,976 | -78,690 | < 0.01% | $1,043,000 | 9 qtrs |
| MORGAN STANLEY | Added | 282,043 | +63,476 | < 0.01% | $762,000 | 9 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 179,802 | -56,276 | < 0.01% | $485,000 | 8 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2017
- Filed
- August 02, 2017
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.